William Blair Starts Newamsterdam Pharma Co NV (NAMS) at Outperform
Tweet Send to a Friend
(Updated - December 19, 2022 7:24 AM EST)
William Blair analyst Matt Phipps initiates coverage on Newamsterdam Pharma Co ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Matt Phipps initiates coverage on Newamsterdam Pharma Co ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


